CLPVASC
CLPVASC is a kidney-targeting cyclic peptide that preferentially distributes to kidney tissue, with utility to enhance kidney targeting of nanocarriers.CLPVASC preferentially distributes to the kidney when displayed on PEG-b-PPS micelles. CLPVASC can be used for the research of acute kidney injury.
For research use only. We do not sell to patients.
- CAS No.: 3106628-26-3
- Formula: C28H47N7O9S2
- Molecular Weight:689.84
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6J (female, 17.5 to 22.5 weeks old, unilateral renal ischemia-reperfusion injury)[1]
-
Dosage:MC loaded with 0.3% w/w DiI, displaying CLPVASC at a 1% molar ratio alongside CYNTTTHRC at a 1% molar ratio, at an overall MC concentration of 17 mg/mL
-
Administration:i.v. (retro-orbital route); single dose
-
Result:Achieved 3.4-fold higher uptake in the ischemia-reperfusion injured kidney compared to the contralateral control kidney.
Showed 2.3-fold higher uptake in the injured kidney than in the lungs.
Exhibited 67% higher uptake in the injured kidney than that of non-targeted MC.
Chemical Information
-
CAS No. 3106628-26-3
-
Molecular Weight 689.84
-
Formula C28H47N7O9S2
-
Synonyms
cyclo(CLPVASC)
-
Sequence
cyclo(Cys-Leu-Pro-Val-Ala-Ser-Cys)
-
Sequence Shortening
cyclo(CLPVASC)
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)